Key Decisions in HIV Care

One patient’s journey from HIV diagnosis to undetectable while trying to lose weight.

Anonymous Patient Released: November 29, 2021

One woman’s journey from a late HIV diagnosis to treatment, rehabilitation, and searching for her purpose.

Anonymous Patient Released: December 27, 2021

In this case example, learn the data supporting guideline recommendations about the consequences of suboptimal CD4+ cell count, whether to intensify therapy, switch ART, and more.

William R. Short, MD, MPH, AAHIVS Released: October 15, 2021

Learn the data supporting guideline recommendations about the consequences of suboptimal CD4+ cell count, whether to intensify therapy, switch ART, and more.

William R. Short, MD, MPH, AAHIVS Released: November 3, 2021

Listen as William R. Short, MD, MPH, AAHIVS, discusses the data supporting guideline recommendations about the consequences of suboptimal CD4+ cell count, whether to intensify therapy, switch ART, and more.

William R. Short, MD, MPH, AAHIVS Released: November 19, 2021

Here’s my take on the need for prophylaxis for Pneumocystis jirovecii pneumonia in virologically suppressed patients, including discussion of dosing and choice of regimen when used.

Roger Bedimo, MD, MS, FACP Released: November 23, 2021

Get my take on ART modification to reduce CVD risk in PWH, including discussion of the growing evidence associating certain ARVs with increased CVD risk.

Jens D. Lundgren, MD, DMSc Released: November 29, 2021

Here are my thoughts on how we should approach late-presenting patients and why it is important to get patients with transmissible HIV into care earlier.

Tristan J. Barber, MA, MD, FRCP Released: December 17, 2021

Read a patient’s perspective on the importance of maintaining adherence to antiretroviral therapy through the challenging effects of aging with long-term HIV.

Anonymous Patient Released: January 11, 2022

In this case example, learn the data and recommendations for treating HIV and HCV in patients who are coinfected, including considerations for HCV treatment as prevention and the impact of HCV treatment on the HIV care cascade.

Mark S. Sulkowski, MD Released: January 19, 2022

Treating tuberculosis in a person with HIV can be complicated for both the healthcare professional and the patient. Here’s my take on choosing an ART regimen for people coinfected with tuberculosis and HIV.

Daria Podlekareva, MD, PhD Released: March 7, 2022

Listen as Mark S. Sulkowski, MD, shares the latest data and recommendations for treating HIV and HCV in patients who are coinfected, including considerations for HCV treatment as prevention and the impact of HCV treatment on the HIV care cascade.

Mark S. Sulkowski, MD Released: February 16, 2022

Learn key considerations for the initiation and management of ART in the setting of opportunistic infections. Topics include current data and recommendations for patients with pneumocystis pneumonia, Kaposi’s sarcoma, cytomegalovirus, and cryptococcal meningitis.

Cristina Mussini, MD William R. Short, MD, MPH, AAHIVS Released: March 21, 2022

Learn key considerations for the use of current and future novel therapies including as prevention, initial treatment, switch strategies, and in heavily-treatment experienced patients with HIV.

Cristina Mussini, MD William R. Short, MD, MPH, AAHIVS Released: April 15, 2022

Learn the data and recommendations for treating HIV and HCV in patients who are coinfected, including considerations for HCV treatment as prevention and the impact of HCV treatment on the HIV care cascade.

Mark S. Sulkowski, MD Released: January 26, 2022

Listen as Jason Schafer, PharmD, MPH, shares the latest data and recommendations for using ART in the inpatient setting, including considerations for drug–drug interactions, renal and hepatic dose adjustments, food effects, swallowing difficulties, and the importance of antiretroviral stewardship to avoid errors.

Jason Schafer, PharmD, MPH Released: March 14, 2022

In this case example, learn the data and recommendations for using ART in the inpatient setting including considerations for drug-drug interactions, renal and hepatic dose adjustments, food effects, swallowing difficulties and the importance of antiretroviral stewardship to avoid errors.

Jason Schafer, PharmD, MPH Released: February 7, 2022

Learn the data and recommendations for using ART in the inpatient setting including considerations for drug-drug interactions, renal and hepatic dose adjustments, food effects, swallowing difficulties and the importance of antiretroviral stewardship to avoid errors.

Jason Schafer, PharmD, MPH Released: February 14, 2022

Learn key considerations when choosing ART for patients with coinfections including for patients with HBV/HIV and TB/HIV.

Daria Podlekareva, MD, PhD Mark S. Sulkowski, MD Released: December 29, 2021

In this on-demand recording of a live webinar, expert faculty review key considerations when choosing ART for patients with coinfections including for patients with HBV/HIV and TB/HIV.

Daria Podlekareva, MD, PhD Mark S. Sulkowski, MD Released: January 10, 2022

In this on-demand recording of a live webinar, expert faculty review key considerations for the use of ART in the setting of opportunistic infections. Topics include current data and recommendations for patients with pneumocystis pneumonia, Kaposi sarcoma, cytomegalovirus, and cryptococcal meningitis.

Cristina Mussini, MD William R. Short, MD, MPH, AAHIVS Released: April 5, 2022

In this on-demand recording of a live webinar, expert faculty review key considerations for the use of current and future HIV novel therapies, including as prevention, initial treatment, switch strategies, and in heavily treatment–experienced patients with HIV.

Cristina Mussini, MD William R. Short, MD, MPH, AAHIVS Released: May 2, 2022